Intellia Therapeutics, Inc design mark 50044535
"Design mark 50044535" is a figurative mark owned by Intellia Therapeutics, Inc., filed at the USPTO on August 11, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since August 11, 2026
- Filed
- August 11, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50044535
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Figurative mark
- 1 class
Who owns Intellia Therapeutics, Inc design mark 50044535
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Intellia Therapeutics, Inc.
NTLA · Cambridge, United States
Representative
Karen K. Won
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C
What the mark covers
The products and services Intellia Therapeutics, Inc design mark 50044535 is filed for, grouped by Nice class.
Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use as a gene editing therapy; Pharmaceutical and biological preparations for treating and managing hereditary angioedema (HAE) and complications caused by hereditary angioedema (HAE); Pharmaceutical and biological preparations for use as a one-time treatment for hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (Type 1 or Type 2); Pharmaceutical and biological preparations for use as a gene editing therapy that inactivates the KLKB1 gene and lowers plasma prekallikrein levels; Pharmaceutical and biological preparations for use as a gene editing therapy for hereditary angioedema (HAE); Pharmaceutical and biological preparations, namely, gene editing preparations for treating and managing swelling attacks; Therapeutic agents in the nature of a CRISPR/Cas9 system for treating hereditary angioedema (HAE); Pharmaceutical and biological preparations for the treatment of hereditary angioedema
What has happened so far
Steps recorded by the USPTO, newest first.
- Teas change of correspondence received
- Applicant/correspondence changes (non-responsive) entered
- Teas change of owner address received
- Teas change of correspondence received
- Attorney/dom.rep.revoked and/or appointed
- Teas revoke/app/change addr of atty/dom rep received
- Applicant/correspondence changes (non-responsive) entered
- Teas change of owner address received
- Teas change of correspondence received
- Attorney/dom.rep.revoked and/or appointed
5 earlier steps on the official record.
About Intellia Therapeutics, Inc design mark 50044535
Who owns the trademark "Design mark 50044535"?
The USPTO trademark "Design mark 50044535" (application 50044535) is owned by Intellia Therapeutics, Inc.
What is the status of "Design mark 50044535"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull Intellia Therapeutics, Inc design mark 50044535 and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019ff622-47f2-719e-9bc7-a3f047f90661
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019ff622-47f2-719e-9bc7-a3f047f90661",
"object": "trademark",
"mark_text": "[Design Mark]",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50044535",
"filing_date": "2026-08-11",
"nice_classes": [
5
],
"owners": [
{
"name": "Intellia Therapeutics, Inc.",
"entity_id": "ent_019eb70a-ad62-7032-a246-031d34afc7b9"
}
]
}